Literature DB >> 23519193

Ventricular assist devices (VAD) therapy: new technology, new hope?

Limael E Rodriguez1, Erik E Suarez, Matthias Loebe, Brian A Bruckner.   

Abstract

Ventricular assist devices are commonly utilized in the treatment of end-stage heart failure. Advances in continuous flow technology have improved efficiency, size, implantability, extended support, and overall patient outcomes. This has led to an expanded role of left ventricular assist device (LVAD) clinical use and applications. This review describes the advances and current state of LVAD devices and provides a future outlook for this technology.

Entities:  

Keywords:  INTERMACS; bridge to transplant; mechanical assist device; ventricular assist device

Mesh：

Year:  2013        PMID： 23519193      PMCID： PMC3600882          DOI： 10.14797/mdcj-9-1-32

Source DB:  PubMed          Journal:  Methodist Debakey Cardiovasc J        ISSN： 1947-6108


  34 in total

Review 1.  Long-term continuous flow left ventricular assist device support and end-organ function: prospects for destination therapy.

Authors:  Mark S Slaughter
Journal:  J Card Surg       Date:  2010-07       Impact factor: 1.620

2.  Design features, developmental status, and experimental results with the Heartmate III centrifugal left ventricular assist system with a magnetically levitated rotor.

Authors:  David J Farrar; Kevin Bourque; Charles P Dague; Christopher J Cotter; Victor L Poirier
Journal:  ASAIO J       Date:  2007 May-Jun       Impact factor: 2.872

3.  Total artificial heart and physical therapy management.

Authors:  Clare Nicholson; Jaime C Paz
Journal:  Cardiopulm Phys Ther J       Date:  2010-06

Review 4.  A review of clinical ventricular assist devices.

Authors:  Daniel Timms
Journal:  Med Eng Phys       Date:  2011-06-12       Impact factor: 2.242

5.  Use of a continuous-flow device in patients awaiting heart transplantation.

Authors:  Leslie W Miller; Francis D Pagani; Stuart D Russell; Ranjit John; Andrew J Boyle; Keith D Aaronson; John V Conte; Yoshifumi Naka; Donna Mancini; Reynolds M Delgado; Thomas E MacGillivray; David J Farrar; O H Frazier
Journal:  N Engl J Med       Date:  2007-08-30       Impact factor: 91.245

6.  Advanced heart failure treated with continuous-flow left ventricular assist device.

Authors:  Mark S Slaughter; Joseph G Rogers; Carmelo A Milano; Stuart D Russell; John V Conte; David Feldman; Benjamin Sun; Antone J Tatooles; Reynolds M Delgado; James W Long; Thomas C Wozniak; Waqas Ghumman; David J Farrar; O Howard Frazier
Journal:  N Engl J Med       Date:  2009-11-17       Impact factor: 91.245

7.  Fifth INTERMACS annual report: risk factor analysis from more than 6,000 mechanical circulatory support patients.

Authors:  James K Kirklin; David C Naftel; Robert L Kormos; Lynne W Stevenson; Francis D Pagani; Marissa A Miller; J T Baldwin; J Timothy Baldwin; James B Young
Journal:  J Heart Lung Transplant       Date:  2013-02       Impact factor: 10.247

8.  Tricuspid annular motion as a predictor of severe right ventricular failure after left ventricular assist device implantation.

Authors:  Sarinya Puwanant; Karen K Hamilton; Charles T Klodell; James A Hill; Richard S Schofield; Timothy S Cleeton; Daniel F Pauly; Juan M Aranda
Journal:  J Heart Lung Transplant       Date:  2008-10       Impact factor: 10.247

9.  Low thromboembolic risk for patients with the Heartmate II left ventricular assist device.

Authors:  Ranjit John; Forum Kamdar; Kenneth Liao; Monica Colvin-Adams; Leslie Miller; Lyle Joyce; Andrew Boyle
Journal:  J Thorac Cardiovasc Surg       Date:  2008-09-14       Impact factor: 5.209

10.  Current trends in implantable left ventricular assist devices.

Authors:  Jens Garbade; Hartmuth B Bittner; Markus J Barten; Friedrich-Wilhelm Mohr
Journal:  Cardiol Res Pract       Date:  2011-05-09       Impact factor: 1.866
View more
  8 in total

1.  Pathological findings in cardiac apex removed during implantation of left ventricular assist devices (LVAD) are non-specific: 13-year-experience at a German Heart Center.

Authors:  Thomas Strecker; Johannes Rösch; Michael Weyand; Abbas Agaimy
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

Review 2.  Approaches to improving exercise capacity in patients with left ventricular assist devices: an area requiring further investigation.

Authors:  Richard Severin; Ahmad Sabbahi; Cemal Ozemek; Shane Phillips; Ross Arena
Journal:  Expert Rev Med Devices       Date:  2019-09-06       Impact factor: 3.166

Review 3.  The practical role of echocardiography in selection, implantation, and management of patients requiring LVAD therapy.

Authors:  Maria Chiara Todaro; Bijoy K Khandheria; Timothy E Paterick; Matt M Umland; Vinay Thohan
Journal:  Curr Cardiol Rep       Date:  2014-04       Impact factor: 2.931

Review 4.  Advancements in mechanical circulatory support for patients in acute and chronic heart failure.

Authors:  Thomas A Csepe; Ahmet Kilic
Journal:  J Thorac Dis       Date:  2017-10       Impact factor: 2.895

Review 5.  Left ventricular assist devices: a kidney's perspective.

Authors:  T R Tromp; N de Jonge; J A Joles
Journal:  Heart Fail Rev       Date:  2015-07       Impact factor: 4.214

Review 6.  Nanomaterials for Cardiac Myocyte Tissue Engineering.

Authors:  Rodolfo Amezcua; Ajay Shirolkar; Carolyn Fraze; David A Stout
Journal:  Nanomaterials (Basel)       Date:  2016-07-19       Impact factor: 5.076

7.  QRS complex fragmentation and survival following left ventricular assist device implantation.

Authors:  Isac C Thomas; David P Cork; Ankit K Bhatia; Hemal M Nayak; Martin C Burke; Joshua D Moss
Journal:  Int J Cardiol Heart Vasc       Date:  2014-11-12

8.  Chest radiographs of cardiac devices (Part 2): Ventricular assist devices.

Authors:  Rishi P Mathew; Timothy Alexander; Vimal Patel; Gavin Low
Journal:  SA J Radiol       Date:  2019-07-31
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.